公开(公告)号：US11051514B2

公开(公告)日：2021-07-06

申请号：US15574775

申请日：2016-05-17

申请人： Mycovia Pharmaceuticals, Inc.

发明人： William J. Hoekstra ,  Christopher M. Yates ,  Robert J. Schotzinger ,  Michael R. Loso ,  Gary D. Gustafson ,  Michael T. Sullenberger ,  Kimberly Steward ,  Javier Delgado ,  Xuelin Wang

IPC分类号： A01N43/653 ,  C07D401/06

摘要： The present invention relates to compounds of Formula (I): wherein R1 is as defined herein, or an acceptable salt, solvate, prodrug or hydrate thereof. The compounds of Formula I are inhibitors of metalloenzymes, such as lanosterol demethylase (CYP51).

公开(公告)号：US20210360921A1

公开(公告)日：2021-11-25

申请号：US17338578

申请日：2021-06-03

申请人： Mycovia Pharmaceuticals, Inc.

发明人： William J. Hoekstra ,  Christopher M. Yates ,  Robert J. Schotzinger ,  Michael R. Loso ,  Gary D. Gustafson ,  Michael T. Sullenberger ,  Kimberly Steward ,  Javier Delgado ,  Xuelin Wang

IPC分类号： A01N43/653 ,  C07D401/06

摘要： The present invention relates to compounds of Formula (I): wherein R1 is as defined herein, or an acceptable salt, solvate, prodrug or hydrate thereof. The compounds of Formula I are inhibitors of metalloenzymes, such as lanosterol demethylase (CYP51).